Alternatives to BreezeBio
BreezeBio is a Biotechnology tool: breezeBio is a genetic medicine company developing a pipeline of precision therapeutics. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to BreezeBio
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Latus Bio54BiotechnologyBoston, USA$151.0MEngineering scalable gene therapies for broader patient populations.
- Website
Sinopia Biosciences54BiotechnologySan Diego, USA$2.2MBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
- Website
Lightcast53BiotechnologyCambridge, United Kingdom$27.0MAI-powered antibody discovery platform.
- Website
mbiomics48BiotechnologyMunich, Germany$12.0MAdvancing scalable microbiome-based therapeutics for severe and chronic diseases.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Houdini Bio42BiotechnologyCambridge, United Kingdom$1.7MEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
- Website FOForlong Biotechnology42BiotechnologyShanghai, China$22.5M
Clinical-stage biotech company developing transformative cytokine therapies.
- Website
Laverock Therapeutics41BiotechnologyCambridge, United Kingdom$10.0MDeveloping disease-responsive advanced therapies through programmable gene control technology.
- Website ACAcurex Biosciences34BiotechnologySan Carlos, USA$1.0M
Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders.
- Website
Coefficient Bio70BiotechnologySan Francisco, United States$15.8BAI safety and research company building reliable, interpretable, and steerable AI systems.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Mammoth Biosciences63BiotechnologyBrisbane, United States$460.0MBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Showing the 20 closest matches. See the rest on the BreezeBio profile.
Compare BreezeBio head to head
Side by side on what each one does, what it costs, and what real users report.